There is a time to grow, there is a time to evolve.
Any limit can be our next frontier.
Welcome to the new era.
On December 19, 2017, Anemocyte is born. It is not just a change of name. Ours, is a real transformation: a natural evolution of our growth path and of the value built piece by piece until today with our clients, suppliers, partners and collaborators.
A new identity, facing a new challenge as a company, with further targets. Moved by passion for innovation, we want to keep improving the life of patients, anticipating and promoting real change in the pharmaceutical industry.
Anemocyte wants to be at the heart of change: we have a key role to play in the field of advanced therapies, through our innovative strength, activated by our several talents that represent the true core of our company.
Anemocyte is talent, innovating Life.
To keep walking this journey together and discover what’s next in the evolution of our company, we invite you to please keep for your record our new information:
Our legal address, fiscal code, VAT number, bank information and shipment address will remain unchanged, as detailed below:
We ask you to please share this communication with all the functions involved in your organization.
We look forward to seeing you soon and are available for any further explanation.
Mr. Marcello Fumagalli